Company profile: Medicus Pharma
1.1 - Company Overview
Company description
- Provider of biotechnology research services that accelerate life sciences and biotech companies through FDA clinical trials, via clinical development programs spanning clinical evaluation, regulatory approval, and market introduction. Through Skinject Inc., develops a dissolvable doxorubicin microneedle patch for non-melanoma skin cancer, particularly basal cell carcinoma. Pursues acquisitions and partnerships to expand its drug development pipeline.
Products and services
- Clinical Development Programs: FDA-focused programs accelerate clinical development of novel, disruptive therapeutic assets by driving clinical evaluation, regulatory approval, and market introduction, expediting progression through FDA clinical trials
- Skinject Inc.: Subsidiary developing and commercializing a dissolvable, doxorubicin-containing microneedle patch array (D-MNA) for the treatment of non-melanoma skin cancer, particularly basal cell carcinoma
- Acquisitions and Partnerships: Qualified initiatives explore opportunities to expand the drug development pipeline through acquisitions and partnerships to address unmet needs in patient safety and efficacy.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medicus Pharma
Noble Pharma
HQ: United States
Website
- Description: Provider of FDA-approved contract development and manufacturing services for extremely palatable animal health products, including formulation and process development; manufacturing of soft chews, creams, ointments, suspensions, tablets, powders, and pastes; clinical supplies; GLP analytical and ICH stability services; regulatory support; packaging with serialization and child-resistant options; and technology transfer and validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noble Pharma company profile →
NorthX Biologics
HQ: Sweden
Website
- Description: Provider of contract development and manufacturing services for biologics from concept to commercial manufacturing; process development upstream/downstream optimization and verification; biopharmaceutical testing (analytical development, method validation, stability); recombinant protein production (microbial and mammalian); viral vector and vaccine development/manufacturing for clinical and commercial stages; GMP/non-GMP plasmid DNA production.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NorthX Biologics company profile →
AnaBios
HQ: United States
Website
- Description: Provider of human-focused contract research services and products for biotech and pharma drug discovery, using ex vivo studies of human donor organs and tissues. Includes ethical human tissue and cell procurement, human primary cells and media, RIN analysis, custom tissue collection, cryopreserved human hepatocytes, and high-quality human heart tissue for cardiovascular preclinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnaBios company profile →
Tentamus Group
HQ: Germany
Website
- Description: Provider of product safety and quality testing through a network of specialized laboratories. Services include analysis of food, water (particularly drinking water), feed, dietary supplements, pharmaceuticals, and agrosciences (fertilizers and crop protection). Capabilities span chemical, instrumental, physico-chemical, microbiological, molecular biological, and mechanical testing to ensure marketability and safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tentamus Group company profile →
Aptus Clinical
HQ: United Kingdom
Website
- Description: Provider of specialist clinical contract research services, offering Catalyst Oncology, a clinical research organization focusing on oncology supporting biotech companies in developing cancer therapies, and Catalyst Flex, multi-therapeutic functional service provider solutions including clinical operations, data management, biostatistics, programming, safety, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aptus Clinical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medicus Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medicus Pharma
2.2 - Growth funds investing in similar companies to Medicus Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medicus Pharma
4.2 - Public trading comparable groups for Medicus Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →